SAN DIEGO, Feb. 5, 2015 (GLOBE NEWSWIRE) -- Zogenix, Inc. (Nasdaq:ZGNX), a pharmaceutical company developing and commercializing products for the treatment of central nervous system (CNS) disorders, today announced that Ann Rhoads, Chief Financial Officer, will present at the Leerink Global Healthcare Conference in New York, NY on February 11, 2015. Ms. Rhoads will participate in a fireside chat presentation and provide a general company update.
|Event:||Leerink Global Healthcare Conference|
|Date:||Wednesday, February 11, 2014|
|Place:||New York City|
|Time:||8:00 am ET / 5:00 am PT|
The presentation will be webcast live and archived for 30 days on Zogenix' Investor Relations website at ir.zogenix.com.
Zogenix, Inc. (Nasdaq:ZGNX) is a pharmaceutical company committed to developing and commercializing therapies that address specific clinical needs for people living with CNS disorders who need innovative treatment alternatives to help them return to normal daily functioning.
CONTACT: Investors Zack Kubow, The Ruth Group 646.536.7020, firstname.lastname@example.orgSource:Zogenix